US 10821163
Process for the production of a DNA vaccine for cancer immunotherapy
granted A61KA61K2039/522A61K2039/523
Quick answer
US patent 10821163 (Process for the production of a DNA vaccine for cancer immunotherapy) held by Vaximm AG expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vaximm AG
- Grant date
- Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/522, A61K2039/523, A61K2039/53, A61K39/0011